English   español  

Navegación por Autor Latorre, Victor

Ir a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
O introducir las primeras letras:  
Mostrando resultados 1 a 10 de 10
DerechosPreviewFecha Public.TítuloAutor(es)Tipo
closedAccessaccesoRestringido.pdf.jpg17-mar-2021Adoptive transfer of ex vivo expanded SARS‐CoV‐2‐specific cytotoxic lymphocytes: A viable strategy for COVID‐19 immunosuppressed patients?Guerreiro, Manuel; Aguilar-Gallardo, Cristóbal; Montoro, Juan; Francés-Gómez, Clara CSIC ORCID; Latorre, Victor; Luna, Irene; Planelles, Dolores; Carrasco, María Paz; Gómez, María Dolores; González-Barbera, Eva M.; Aguado, Cristina; Sempere, Amparo; Solves, Pilar; Gómez-Seguí, Inés; Balaguer-Rosello, Aitana; Louro, Alberto; Perla, Aurora; Larrea, Luis; Sanz, Jaime; Arbona, Cristina; Rubia, Javier de la; Geller, Ron CSIC ORCID ; Sanz, Miguel Ángel CSIC ORCID; Sanz, Guillermo; Piñana, José Luisartículo
openAccesschaperoningdirect.pdf.jpg2018Chaperoning the Mononegavirales: Current knowledge and future directionsLatorre, Victor; Mattenberger, Florian CSIC ORCID; Geller, Ron CSIC ORCID artículo
openAccessglobalcasip.pdf.jpg2021Globally defining the effects of mutations in a picornavirus capsidMattenberger, Florian CSIC ORCID; Latorre, Victor; Tirosh, Omer; Stern, Adi; Geller, Ron CSIC ORCID artículo
openAccessidenrepli.pdf.jpg2022Identification of cytoplasmic chaperone networks relevant for respiratory syncytial virus replicationLatorre, Victor; Geller, Ron CSIC ORCID artículo
openAccessinferenceimmu.pdf.jpg2021Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassaysValdivia, Arantxa; Torres, Ignacio; Latorre, Victor; Francés-Gómez, Clara CSIC ORCID; Albert, Eliseo; Gozalbo-Rovira, Roberto CSIC ORCID ; Alcaraz, María Jesús; Buesa, Javier; Rodríguez-Díaz, Jesús; Geller, Ron CSIC ORCID ; Navarro, Davidartículo
openAccessSARS-CoV-2 antibodies.pdf.jpg24-jul-2020SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 PatientsGozalbo-Rovira, Roberto CSIC ORCID ; Giménez, Estela; Latorre, Victor; Francés-Gómez, Clara CSIC ORCID; Albert, Eliseo; Buesa, Javier; Marina, Alberto CSIC ORCID ; Blasco, María Luisa; Signes-Costa, Jaime; Rodríguez-Díaz, Jesús; Geller, Ron CSIC ORCID ; Navarro, Davidpreprint
openAccessSARS-CoV-2 antibodies.pdf.jpg1-sep-2020SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patientsGozalbo-Rovira, Roberto CSIC ORCID ; Giménez, Estela; Latorre, Victor; Francés-Gómez, Clara CSIC ORCID; Albert, Eliseo; Buesa, Javier; Marina, Alberto CSIC ORCID ; Blasco, María Luisa; Signes-Costa, Jaime; Rodríguez-Díaz, Jesús; Geller, Ron CSIC ORCID ; Navarro, Davidartículo
openAccessaccesoRestringido.pdf.jpg25-sep-2020Suitability of Two Rapid Lateral Flow Immunochromatographic Assays for Predicting SARS-CoV-2 Neutralizing Activity of SeraValdivia, Arantxa; Torres, Ignacio; Latorre, Victor; Francés-Gómez, Clara CSIC ORCID; Ferrer, Josep; Forque, Lorena; Costa, Rosa; Solano de la Asunción, Carlos; Huntley, Dixie; Gozalbo-Rovira, Roberto CSIC ORCID ; Buesa, Javier; Giménez, Estela; Rodríguez-Díaz, Jesús; Geller, Ron CSIC ORCID ; Navarro, Davidpreprint
closedAccessaccesoRestringido.pdf.jpg2021Suitability of two rapid lateral flow immunochromatographic assays for predicting SARS‐CoV‐2 neutralizing activity of seraValdivia, Arantxa; Torres, Ignacio; Latorre, Victor; Francés-Gómez, Clara CSIC ORCID; Ferrer, Josep; Forque, Lorena; Costa, Rosa; Solano de la Asunción, Carlos; Huntley, Dixie; Gozalbo-Rovira, Roberto CSIC ORCID ; Buesa, Javier; Giménez, Estela; Rodríguez-Díaz, Jesús; Geller, Ron CSIC ORCID ; Navarro, Davidartículo
openAccess2022Supplementary Material for Identification of cytoplasmic chaperone networks relevant for respiratory syncytial virus replicationLatorre, Victor; Geller, Ron CSIC ORCID dataset